02/12/2025
π¨ How much do we really know about Cardiac Amyloidosis in Africa?
Cardiac amyloidosis remains underdiagnosed across the continent, often masked by labels like βHFpEF,β βhypertensive heart disease,β or unexplained conduction abnormalities.
To address this gap, the Kenya Cardiac Society (KCS), in collaboration with CRK Clinical Research Key (NGO), Pan-African Society of Cardiology (PASCAR), and regional partners, is conducting a short survey to understand current awareness, diagnostic capacity, and clinical practice related to cardiac amyloidosis among healthcare providers.
π It only takes 12 minutes β but your response can have a big impact.
Your input will directly support the KCS Registry Program on Cardiac Amyloidosis Screening & Implementation Science, helping shape national and continental strategies.
π Survey link:
https://lnkd.in/e4aWGw2M
Thank you for contributing to better diagnosis, earlier detection, and improved patient outcomes across Africa.
Together with KCS, PASCAR, and partners, we can uncover the true burden of cardiac amyloidosis.